Ingrezza Side Effects
Generic name: valbenazine
Medically reviewed by Drugs.com. Last updated on Mar 15, 2022.
Note: This document contains side effect information about valbenazine. Some of the dosage forms listed on this page may not apply to the brand name Ingrezza.
Common side effects of Ingrezza include: drowsiness, fatigue, and sedated state. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to valbenazine: oral capsule
Side effects requiring immediate medical attention
Along with its needed effects, valbenazine (the active ingredient contained in Ingrezza) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking valbenazine:
- Absence of or decrease in body movement
- clumsiness or unsteadiness
- inability to sit still
- loss of balance control
- need to keep moving
- trembling and shaking of the fingers or hands
- trouble walking
Incidence not known
- hives or welts, itching, or red skin rash
- irregular heartbeat recurrent
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
Side effects not requiring immediate medical attention
Some side effects of valbenazine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Blurred vision
- decrease in the frequency of urination
- decrease in urine volume
- difficulty having a bowel movement (stool)
- difficulty in passing urine (dribbling)
- dry mouth
- painful urination
- sleepiness or unusual drowsiness
- Fear or nervousness
- muscle pain or stiffness
- pain in the joints
- trouble sleeping
For Healthcare Professionals
Applies to valbenazine: oral capsule
-The most common adverse reaction (5% or more and twice the rate of placebo) was somnolence.
-A total of 3% of patients discontinued treatment because of adverse reactions.[Ref]
Very common (10% or more): Somnolence/fatigue/sedation (10.9%)
Common (1% to 10%): Anticholinergic effects (dry mouth, constipation, attention disturbance, blurred vision, urinary retention), balance disorders/fall/gait disturbance/dizziness, headache, akathisia/restlessness, drooling, dyskinesia,
non-akathisia extrapyramidal symptoms[Ref]
Common (1% to 10%): Vomiting, nausea[Ref]
Common (1% to 10%): Increased alkaline phosphatase and bilirubin[Ref]
Common (1% to 10%): Increased blood glucose, increased weight, increased prolactin[Ref]
Common (1% to 10%): Arthralgia[Ref]
Common (1% to 10%): Respiratory infections[Ref]
Frequently asked questions
- How much does it cost?
- Ingrezza mechanism of action: How does it work?
- What condition is Ingrezza used to treat?
- Austedo vs Ingrezza: How do they compare?
- Which pharmacies can dispense Ingrezza?
- How long does it take for Ingrezza to work?
- Does Ingrezza cause weight gain?
- How effective is Ingrezza?
- Can Ingrezza capsules be opened?
More about Ingrezza (valbenazine)
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: VMAT2 inhibitors
- FDA approval history
Related treatment guides
1. "Product Information. Ingrezza (valbenazine)." Neurocrine Biosciences, Inc., San Diego, CA.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.